eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Sanofi Pasteur MSD Limited
Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/02/2009
PIL REVAXIS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/02/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 29/04/2008 and displayed until 24/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 17/04/2008 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 24/04/2007 and displayed until 17/04/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 20/04/2006 and displayed until 24/04/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  diphtheria, tetanus and poliomyelitis